我的职责是在肺癌治疗领域, 特别是在免疫肿瘤学的后期临床试验中. 这是一个非常令人兴奋的领域, 尤其是现在,澳门葡京赌博游戏正在突破界限, 看到想法和概念变成现实. 
 

The idea of using the immune system to kill off cancer cells has been around for a long time, but now it is a reality: Immuno-oncology and building further on this concept is the new frontier and a big hope in the treatment of cancer.

Kirsha Naicker 全球研究医学科学家领袖,免疫肿瘤学


作为高级项目科学家, I have been involved in the everyday scientific and medical aspects of a large global clinical trial in Non-Small-Cell Lung Cancer. 2019年1月, I stepped into the Global Study Medical Scientist Leader role where I am now the clinical/scientific lead of a clinical trial within the Immuno-oncology team. I work in a global matrix team – planning and executing clinical trials across the globe – and I am extremely fortunate to work with some of the most experienced, 我所见过的最聪明、最脚踏实地的人.

 

Knowing that we can improve the lives of patients and thereby their families all over the world is incredibly inspiring. 澳门葡京赌博游戏可以贡献很多, and I look forward to the breakthroughs that we will achieve together through hard work and commitment.

Kirsha Naicker 全球免疫肿瘤学医学科学家研究负责人


我对科学的热情从小就伴随着我. 随着岁月的流逝,我渐渐长大, 我对人类科学的兴趣, 疾病, the way the human body operates and our ability to influence 疾病 grew with me. I completed my Bachelor of Science (BSc) degree at University College Dublin (UCD) in Cell and Molecular Biology after which I pursued a Master of Science (MSc) in Molecular Medicine in Trinity College Dublin (TCD). I then went onto further education and completed my PHD in UCD, researching the role of SATB proteins in colorectal cancer in 2013. I spent some time travelling upon completion of my PHD and I then moved to London, UK in early 2014 to work as an 肿瘤学 Business Insights Analyst focussing on oncology products for a global information and technology resources company. 利用这段经历以及我对科学的热情, I joined AstraZeneca in 2015 as a Medical Scientist in immuno-oncology. 肿瘤学 has greatly interested and inspired me through the years as I don’t think I know anyone who has not been touched by this 疾病 in some way, 所以对我来说, 肿瘤学 is a very worthwhile and rewarding area in which to grow and learn personally and professionally.


Kirsha Naicker

电流的作用

全球免疫肿瘤学医学科学家研究负责人

2019年1月至今

全球免疫肿瘤学医学科学家研究负责人: leading the design, 行为, 数据监控, 数据解释和报告, ensuring that clinical studies operate to the highest ethical and safety standards.

2017-2018

全球第三期研究的首席科学家. Setup the medical scientist’s forum in Immuno-oncology late stage development. Active member of the initiative ‘Our Future Reimagined’, improving the way we work.

2015-2018

Medical scientist involved in all scientific and medical activities in a Global phase 3 Study. Founding member of the Immuno-oncology Clinical study protocol and Investigator Brochure development standards team.

特色的出版物


SATB2 in Combination with Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

美国外科病理学杂志- 2011. 发布链接.

IL-23是促增殖的, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

Baird等人肺癌IL-23. 发布链接

SATB2缺失与结直肠癌(CRC)的免疫环境

临床肿瘤学杂志2018. 发布链接.

Abstract 698: The loss of SATB2 promotes ulcerative colitis-related colon cancer progression through altered localized inflammatory response

癌症研究2018. 发布链接.

Abstract LB-444: SATB2 is a novel prognostic factor in colorectal cancer

癌症研究2012. 发布链接.

加入澳门葡京网赌游戏

并帮助澳门葡京赌博游戏提供改变生活的药物 

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.